198 related articles for article (PubMed ID: 33928557)
21. Chimeric antigen receptor-modified human regulatory T cells that constitutively express IL-10 maintain their phenotype and are potently suppressive.
Mohseni YR; Saleem A; Tung SL; Dudreuilh C; Lang C; Peng Q; Volpe A; Adigbli G; Cross A; Hester J; Farzaneh F; Scotta C; Lechler RI; Issa F; Fruhwirth GO; Lombardi G
Eur J Immunol; 2021 Oct; 51(10):2522-2530. PubMed ID: 34320225
[TBL] [Abstract][Full Text] [Related]
22. Isolation of human CD4/CD8 double-positive, graft-versus-host disease-protective, minor histocompatibility antigen-specific regulatory T cells and of a novel HLA-DR7-restricted HY-specific CD4 clone.
Eljaafari A; Yuruker O; Ferrand C; Farre A; Addey C; Tartelin ML; Thomas X; Tiberghien P; Simpson E; Rigal D; Scott D
J Immunol; 2013 Jan; 190(1):184-94. PubMed ID: 23225889
[TBL] [Abstract][Full Text] [Related]
23. Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity.
Ghanem MH; Bolivar-Wagers S; Dey B; Hajduczki A; Vargas-Inchaustegui DA; Danielson DT; Bundoc V; Liu L; Berger EA
Cytotherapy; 2018 Mar; 20(3):407-419. PubMed ID: 29306566
[TBL] [Abstract][Full Text] [Related]
24. Characterisation of Foxp3 splice variants in human CD4+ and CD8+ T cells--identification of Foxp3Δ7 in human regulatory T cells.
Kaur G; Goodall JC; Jarvis LB; Hill Gaston JS
Mol Immunol; 2010; 48(1-3):321-32. PubMed ID: 20688398
[TBL] [Abstract][Full Text] [Related]
25. [An experimental study of CD4 targeted chimeric antigen receptor modified T cell with anti-lymphoma activity].
Chen GH; Huang HW; Wang Y; Liu HW; Xu LJ; Ma X; Xue SL; He XF; Wang Y; Gu B; Li CX; Qiu HY; Tang XW; Jin ZM; Miao M; Sun AN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2018 Feb; 39(2):148-152. PubMed ID: 29562451
[No Abstract] [Full Text] [Related]
26. A new approach to CAR T-cell gene engineering and cultivation using piggyBac transposon in the presence of IL-4, IL-7 and IL-21.
Ptáčková P; Musil J; Štach M; Lesný P; Němečková Š; Král V; Fábry M; Otáhal P
Cytotherapy; 2018 Apr; 20(4):507-520. PubMed ID: 29475789
[TBL] [Abstract][Full Text] [Related]
27. In Vitro Differentiation of T Cell: From CAR-Modified T-iPSC.
Ueda T; Kaneko S
Methods Mol Biol; 2019; 2048():85-91. PubMed ID: 31396933
[TBL] [Abstract][Full Text] [Related]
28. Generation of Murine Chimeric Antigen Receptor T Cells for Adoptive T Cell Therapy for Melanoma.
Barber A
Methods Mol Biol; 2021; 2265():645-654. PubMed ID: 33704745
[TBL] [Abstract][Full Text] [Related]
29. CD11c(high)CD8+ regulatory T cell feedback inhibits CD4 T cell immune response via Fas ligand-Fas pathway.
Chen Z; Han Y; Gu Y; Liu Y; Jiang Z; Zhang M; Cao X
J Immunol; 2013 Jun; 190(12):6145-54. PubMed ID: 23677464
[TBL] [Abstract][Full Text] [Related]
30. Lentivirus-mediated gene transfer and expression in established human tumor antigen-specific cytotoxic T cells and primary unstimulated T cells.
Zhou X; Cui Y; Huang X; Yu Z; Thomas AM; Ye Z; Pardoll DM; Jaffee EM; Cheng L
Hum Gene Ther; 2003 Jul; 14(11):1089-105. PubMed ID: 12885348
[TBL] [Abstract][Full Text] [Related]
31. Exclusive Transduction of Human CD4+ T Cells upon Systemic Delivery of CD4-Targeted Lentiviral Vectors.
Zhou Q; Uhlig KM; Muth A; Kimpel J; Lévy C; Münch RC; Seifried J; Pfeiffer A; Trkola A; Coulibaly C; von Laer D; Wels WS; Hartwig UF; Verhoeyen E; Buchholz CJ
J Immunol; 2015 Sep; 195(5):2493-501. PubMed ID: 26232436
[TBL] [Abstract][Full Text] [Related]
32. Chimeric Antigen Receptors Targeting Human Cytomegalovirus.
Ali A; Chiuppesi F; Nguyen M; Hausner MA; Nguyen J; Kha M; Iniguez A; Wussow F; Diamond DJ; Yang OO
J Infect Dis; 2020 Aug; 222(5):853-862. PubMed ID: 32285133
[TBL] [Abstract][Full Text] [Related]
33. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
[TBL] [Abstract][Full Text] [Related]
34. Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy.
Mercier-Letondal P; Marton C; Deschamps M; Ferrand C; Vauchy C; Chenut C; Baguet A; Adotévi O; Borg C; Galaine J; Godet Y
Hum Gene Ther; 2018 Oct; 29(10):1202-1212. PubMed ID: 30136612
[TBL] [Abstract][Full Text] [Related]
35. Interleukin 15 and CD4⁺ T cells cooperate to promote small intestinal enteropathy in response to dietary antigen.
Korneychuk N; Ramiro-Puig E; Ettersperger J; Schulthess J; Montcuquet N; Kiyono H; Meresse B; Cerf-Bensussan N
Gastroenterology; 2014 Apr; 146(4):1017-27. PubMed ID: 24361466
[TBL] [Abstract][Full Text] [Related]
36. Production of human CAR-NK cells with lentiviral vectors and functional assessment
Portillo AL; Hogg R; Ashkar AA
STAR Protoc; 2021 Dec; 2(4):100956. PubMed ID: 34825217
[TBL] [Abstract][Full Text] [Related]
37. Cooperation of human tumor-reactive CD4+ and CD8+ T cells after redirection of their specificity by a high-affinity p53A2.1-specific TCR.
Kuball J; Schmitz FW; Voss RH; Ferreira EA; Engel R; Guillaume P; Strand S; Romero P; Huber C; Sherman LA; Theobald M
Immunity; 2005 Jan; 22(1):117-29. PubMed ID: 15664164
[TBL] [Abstract][Full Text] [Related]
38. Production and Concentration of Lentivirus for Transduction of Primary Human T Cells.
Kennedy A; Cribbs AP
Methods Mol Biol; 2016; 1448():85-93. PubMed ID: 27317175
[TBL] [Abstract][Full Text] [Related]
39. CAR Gene Delivery by T-cell Targeted Lentiviral Vectors is Enhanced by Rapamycin Induced Reduction of Antiviral Mechanisms.
Charitidis FT; Adabi E; Ho N; Braun AH; Tierney C; Strasser L; Thalheimer FB; Childs L; Bones J; Clarke C; Buchholz CJ
Adv Sci (Weinh); 2023 Dec; 10(35):e2302992. PubMed ID: 37904721
[TBL] [Abstract][Full Text] [Related]
40. Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetes.
Zhang L; Sosinowski T; Cox AR; Cepeda JR; Sekhar NS; Hartig SM; Miao D; Yu L; Pietropaolo M; Davidson HW
J Autoimmun; 2019 Jan; 96():50-58. PubMed ID: 30122420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
